EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritisLinda Fernandes, T. P. M. Vliet Vlieland, Kåre Birger Hagen et al.|Annals of the Rheumatic Diseases|2013Cited by 1.4k
A Phase <scp>II</scp> Trial of Lutikizumab, an Anti–Interleukin‐1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With SynovitisRoy Fleischmann, Marc C. Levesque, Charles G. Peterfy et al.|Arthritis & Rheumatology|2019Cited by 209